Abstract: An activity-driven, profitability calculation method and system track expenses and/or income associated with each activity initiated by customers or accounts. The method detects and identifies activities associated with an account, and obtains rate information associated with the identified activities. The rate information specifies any expenses or incomes associated with the identified activities. A profitability status related to the account, such as an amount of profits or loss, is updated based on the rate information associated with the identified activities. The determined profitability status of the account or customer may be used to determine a service type or level that would be received by the account or customer.

Abstract: The present invention relates to the stable solid orally administrable pharmaceutical formulation of Amlodipine Maleate. The invention also describes the process of producing such stable formulations and more specifically a direct compression method of producing tablet formulations. The tablet formulation of Amlodipine Maleate thus prepared is bioequivalent to the tablets containing Amlodipine Besylate salt commercially available with the brand name of Norvasc. The formulation also avoids the common problem of sticking observed during manufacturing.

Abstract: The present invention relates to the stable solid orally administrable pharmaceutical formulation of Amlodipine Maleate. The invention also describes the process of producing such stable formulations and more specifically a direct compression method of producing tablet formulations. The tablet formulation of Amlodipine Maleate thus prepared is bioequivalent to the tablets containing Amlodipine Besylate salt commercially available with the brand name of Norvasc. The formulation also avoids the common problem of sticking observed during manufacturing.